PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Huoxiang Zhengqi (HXZQ) oral liquid (which contains E. ciliata) showed a significant reduction in Eczema Area and Severity Index (EASI) scores compared to placebo (p = 0.033) [PMID:40839987].
HXZQ oral liquid was assessed for superiority over placebo in adult patients [PMID:41297321].
Huoxiang Zhengqi Pills combined with conventional treatment or norfloxacin tablets showed clinical efficacy [PMID:31602833].
Huoxiang Zhengqi formulas were found to be more effective than western medicine in some studies (RR 1.2) [PMID:29071852].
No significant difference in the improvement rate of clinical symptoms was found between Huoxiang Zhengqi dropping pills combined with Lianhua Qingwen granules and other treatment arms [PMID:32781283].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36234947 (2022) — Elsholtzia ciliata (Thunb.) Hyland: A Review of Phytochemistry and Pharmacology. · Molecules (Basel, Switzerland)
- 2.PMID: 40839987 (2025) — Chinese herbal formula Huoxiang Zhengqi Qral liquid for atopic dermatitis: The CHARM randomized controlled trial. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 3.PMID: 40412777 (2025) — Anti-inflammatory effects of Elsholtzia ciliata extract on Poly I:C-treated RAW264.7 cells. · Journal of ethnopharmacology
- 4.PMID: 37895935 (2023) — Elsholtzia ciliata Essential Oil Exhibits a Smooth Muscle Relaxant Effect. · Pharmaceuticals (Basel, Switzerland)
- 5.PMID: 31602833 (2019)